ChemMedChem最新文献

筛选
英文 中文
Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability. 虫草素衍生物增强生物活性和稳定性的分子工程研究。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-02-05 DOI: 10.1002/cmdc.202400979
Yiming Gu, Wei Yu, Xiang Li, Yingjie Fan, Yanan Liu, Jumreang Tummatorn, Siyu Jiang, Jingyue Yang
{"title":"Molecular Engineering of Cordycepin Derivatives for Enhanced Biological Activity and Stability.","authors":"Yiming Gu, Wei Yu, Xiang Li, Yingjie Fan, Yanan Liu, Jumreang Tummatorn, Siyu Jiang, Jingyue Yang","doi":"10.1002/cmdc.202400979","DOIUrl":"10.1002/cmdc.202400979","url":null,"abstract":"<p><p>To address the metabolic instability of cordycepin induced by adenosine deaminase (ADA) and to enhance its bioactivity, this study developed eleven novel cordycepin derivatives using molecular engineering techniques. By incorporating sterically hindered protective groups and modifying the glycosyl moiety, the research aimed to improve both stability and efficacy. Antibacterial tests revealed that five derivatives showed significantly greater activity against pathogenic strains compared to cordycepin, with better compatibility with probiotics. Compound 2 c demonstrated moderate antitumor activity against K562 and MGC-803 cells, with IC<sub>50</sub> values of 42.21 μM and 27.79 μM, respectively. Additionally, compound 4 b demonstrated notable DPPH free radical scavenging ability. These compounds also showed improved stability in ADA solutions, providing valuable insights into the structure-activity relationships of cordycepin derivatives.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202400979"},"PeriodicalIF":3.6,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143187823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and Antibacterial Properties of 3-Amino-β-Lactams Bearing a Heteroatom-Containing C4 Substituent. 含杂原子C4取代基3-氨基β-内酰胺的合成及抗菌性能。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-02-05 DOI: 10.1002/cmdc.202400994
Kato Bredael, Fien Vanhecke, Emma Vandenheede, Christian V Stevens, Stanislav Gobec, Matthias D'hooghe
{"title":"Synthesis and Antibacterial Properties of 3-Amino-β-Lactams Bearing a Heteroatom-Containing C4 Substituent.","authors":"Kato Bredael, Fien Vanhecke, Emma Vandenheede, Christian V Stevens, Stanislav Gobec, Matthias D'hooghe","doi":"10.1002/cmdc.202400994","DOIUrl":"10.1002/cmdc.202400994","url":null,"abstract":"<p><p>The rise of antimicrobial resistance has spurred the search for innovative antibiotics, with monocyclic 3-amino-β-lactams - aztreonam standing out as key example - showing significant potential. In particular, C4-functionalized 3-amino-β-lactams have emerged as a promising subclass that can potentially improve the activity, stability and cellular permeability of the compounds. This review outlines various synthetic methodologies available for the construction of 3-amino-β-lactams bearing a heteroatom-containing substituent at C4, with the heteroatom connected to the ring system either directly or via a methylene bridge. Special attention is devoted to 3-amino-4-hydroxymethyl-β-lactams and 3-amino-4-acetoxy-β-lactams as versatile synthetic intermediates. Moreover, the effect of these C4 substituents on the biological activity of the corresponding 3-amino-β-lactams is discussed in detail. A better understanding of synthetic protocols and antibacterial properties related to this underexplored class of monocyclic 3-amino-β-lactams might contribute to address the current antibiotics problems we are facing more efficiently.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202400994"},"PeriodicalIF":3.6,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143187827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Front Cover: 3’-Dehydroxypurpurogallin-4-Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure-Activity Relationship Analysis, and Structural Characterization of Protein Complex (ChemMedChem 3/2025) 前封面:3 ' -Dehydroxypurpurogallin-4-Carboxamides作为甲型流感内切酶抑制剂:合成、结构-活性关系分析和蛋白质复合物的结构表征(ChemMedChem 3/2025)
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-02-04 DOI: 10.1002/cmdc.202580301
Michal Kráľ, Tomáš Kotačka, Róbert Reiberger, Gabriela Panýrková, Kateřina Radilová, Zuzana Osifová, Miroslav Flieger, Jan Konvalinka, Pavel Majer, Milan Kožíšek, Aleš Machara
{"title":"Front Cover: 3’-Dehydroxypurpurogallin-4-Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure-Activity Relationship Analysis, and Structural Characterization of Protein Complex (ChemMedChem 3/2025)","authors":"Michal Kráľ,&nbsp;Tomáš Kotačka,&nbsp;Róbert Reiberger,&nbsp;Gabriela Panýrková,&nbsp;Kateřina Radilová,&nbsp;Zuzana Osifová,&nbsp;Miroslav Flieger,&nbsp;Jan Konvalinka,&nbsp;Pavel Majer,&nbsp;Milan Kožíšek,&nbsp;Aleš Machara","doi":"10.1002/cmdc.202580301","DOIUrl":"https://doi.org/10.1002/cmdc.202580301","url":null,"abstract":"<p>The image shows a scene where the mushroom motif is linked to the chemical formulas of purpurogallin derivatives – colchicine, fomenanthriol, and aurantricholone – natural pigments in mushroom caps. These compounds appear as orange, red, or brown dyes, echoing the mushrooms’ colors. It also represents the mushroom season, popular in Europe during autumn. A blue “shield” symbolizes the protective effect of our developed purpurogallines, which block influenza endonuclease, depicted as scissors ready to cleave RNA. More details can be found in article 10.1002/cmdc.202400577 by Milan Kožíšek, Aleš Machara, and co-workers.<figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure>\u0000 </p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"20 3","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202580301","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143111882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover Feature: Diversity Oriented Strategy (DOS) for the Efficient Synthesis of Benzofuro[2,3-b]pyridine Derivatives with Anticancer Activity (ChemMedChem 3/2025) 封面专题:多样性导向策略(DOS)高效合成具有抗癌活性的苯并呋喃[2,3-b]吡啶衍生物(ChemMedChem 3/2025)
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-02-04 DOI: 10.1002/cmdc.202580302
Reymark Ereje, Jantana Yahuafai, Theeranuch Jaroenchuensiri, Patcharaporn Supakijjanusorn, Sukanya Unson, Borwornlak Toopradab, Thanyada Rungrotmongkol, Somsak Pianwanit, Chanat Aonbangkhen, Tanatorn Khotavivattana
{"title":"Cover Feature: Diversity Oriented Strategy (DOS) for the Efficient Synthesis of Benzofuro[2,3-b]pyridine Derivatives with Anticancer Activity (ChemMedChem 3/2025)","authors":"Reymark Ereje,&nbsp;Jantana Yahuafai,&nbsp;Theeranuch Jaroenchuensiri,&nbsp;Patcharaporn Supakijjanusorn,&nbsp;Sukanya Unson,&nbsp;Borwornlak Toopradab,&nbsp;Thanyada Rungrotmongkol,&nbsp;Somsak Pianwanit,&nbsp;Chanat Aonbangkhen,&nbsp;Tanatorn Khotavivattana","doi":"10.1002/cmdc.202580302","DOIUrl":"https://doi.org/10.1002/cmdc.202580302","url":null,"abstract":"<p>The cover feature represents the beauty of interconnectedness amid diversity. The variation of each part shows that it may look random at first, but the connectivity of every fragment reveals a pattern of the union of its pieces showing that no matter different things are, there is an exceptional force binding us together. This concept holds true in diversifying the benzofuropyridine moiety using different functionality resulting into a more comprehensive understanding of its substitution patterns. More details can be found in article 10.1002/cmdc.202400514 by Tanatorn Khotavivattana and co-workers.<figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure>\u0000 </p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"20 3","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202580302","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143111883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Structure-Atropisomer Stability Relationship in Selective MCL-1 Inhibitors. 选择性MCL-1抑制剂的结构-缩二聚体稳定性关系。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-02-03 DOI: 10.1002/cmdc.202400970
Szabolcs Sipos, Barbara Balazs, Tamas Gati, Márton Csékei, Mihály Kováacs, Zoltan Szlavik, Attila Paczal, Balázs Bálint, James B Murray, James Davidson, Roderick E Hubbard, Gaëtane Le Toumelin-Braizat, Ana Leticia Maragno, Olivier Geneste, András Stirling, András Kotschy
{"title":"Structure-Atropisomer Stability Relationship in Selective MCL-1 Inhibitors.","authors":"Szabolcs Sipos, Barbara Balazs, Tamas Gati, Márton Csékei, Mihály Kováacs, Zoltan Szlavik, Attila Paczal, Balázs Bálint, James B Murray, James Davidson, Roderick E Hubbard, Gaëtane Le Toumelin-Braizat, Ana Leticia Maragno, Olivier Geneste, András Stirling, András Kotschy","doi":"10.1002/cmdc.202400970","DOIUrl":"10.1002/cmdc.202400970","url":null,"abstract":"<p><p>Atropisomersm is an emerging feature in recent drug candidates due to the increasing complexity of the targeted protein surfaces. The developability of the drug candidates requires that their atropisomer interconversion is either fast or very slow at ambient temperature therefore the understanding and predictability of the isomerization rate is of great importance. Through a series of selective MCL-1 inhibitors we studied how structural features influence the interconversion of atropisomers. Besides basic observations such as stability in solution, we also carried out NMR kinetics at varying temperatures and a quantum chemical assessment of the isomerization process. The results of our theoretical studies and experimental investigations matched nicely when it came to predicting the presence or absence of isomerization at ambient temperature. For certain compounds we also measured the rotational barrier that fitted nicely the predicted values. The better understanding of how structural elements impact atropisomer stability enables the more efficient optimization of this important feature.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202400970"},"PeriodicalIF":3.6,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143078076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxidative Coupling of Guanidines and Isocyanides Catalyzed by Nickel(II): Access to Imidazoline Derivatives with Antibacterial Activity 镍催化下胍和异氰酸酯的氧化偶联:一种具有抗菌活性的咪唑啉衍生物的制备方法。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-02-02 DOI: 10.1002/cmdc.202400904
Georgii A. Gavrilov, Tuan K. Nguyen, Dr. Svetlana A. Katkova, Dr. Nikolai V. Rostovskii, Dr. Elizaveta V. Rogacheva, Dr. Liudmila A. Kraeva, Dr. Mikhail A. Kinzhalov
{"title":"Oxidative Coupling of Guanidines and Isocyanides Catalyzed by Nickel(II): Access to Imidazoline Derivatives with Antibacterial Activity","authors":"Georgii A. Gavrilov,&nbsp;Tuan K. Nguyen,&nbsp;Dr. Svetlana A. Katkova,&nbsp;Dr. Nikolai V. Rostovskii,&nbsp;Dr. Elizaveta V. Rogacheva,&nbsp;Dr. Liudmila A. Kraeva,&nbsp;Dr. Mikhail A. Kinzhalov","doi":"10.1002/cmdc.202400904","DOIUrl":"10.1002/cmdc.202400904","url":null,"abstract":"<p>A novel and concise approach to rare 2,3,5-triamino-imidazole scaffolds <i>via</i> Ni-catalyzed coupling of alkylisocyanides and <i>N,N</i>′-diarylguanidines has been developed. This reaction features include mild conditions (thermal or visible light activation), a wide substrate scope, and high efficiency. The coupling proceeds through a Ni<sup>II</sup>/Ni<sup>IV</sup> catalytic cycle, involving two-electron aerobic oxidation and the sequential insertion of two isocyanide units into Ni−N bonds.Testing these compounds against pathogens of the ESKAPE panel showed their high activity with a minimum inhibitory concentration down to 0.38 μg/mL.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"20 7","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143078073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lamellarin D Acts as an Inhibitor of Type I Collagen Production. 薄层蛋白D作为I型胶原蛋白生成的抑制剂。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-01-30 DOI: 10.1002/cmdc.202401001
Daisuke Okuno, Noriho Sakamoto, Hideki Hayashi, Tsutomu Fukuda, Yoshiko Akiyama, Chiaki Iketani, Ritsuko Murakami, Takatomo Tokito, Takuto Miyamura, Hirokazu Yura, Takashi Kido, Hiroshi Ishimoto, Shinnosuke Takemoto, Takahiro Takazono, Tomoya Nishino, Yuji Ishimatsu, Jun Ishihara, Kohsuke Takeda, Yoshimasa Tanaka, Hiroshi Mukae
{"title":"Lamellarin D Acts as an Inhibitor of Type I Collagen Production.","authors":"Daisuke Okuno, Noriho Sakamoto, Hideki Hayashi, Tsutomu Fukuda, Yoshiko Akiyama, Chiaki Iketani, Ritsuko Murakami, Takatomo Tokito, Takuto Miyamura, Hirokazu Yura, Takashi Kido, Hiroshi Ishimoto, Shinnosuke Takemoto, Takahiro Takazono, Tomoya Nishino, Yuji Ishimatsu, Jun Ishihara, Kohsuke Takeda, Yoshimasa Tanaka, Hiroshi Mukae","doi":"10.1002/cmdc.202401001","DOIUrl":"10.1002/cmdc.202401001","url":null,"abstract":"<p><p>Idiopathic pulmonary fibrosis (IPF) is a progressive and chronic interstitial lung disease characterized by irreversible loss of lung function and a poor prognosis. Type I collagen, a major component of the extracellular matrix, plays a central role in the pathogenesis of fibrosis and is considered a key molecular target for therapeutic intervention. While current anti-fibrotic therapies demonstrate limited efficacy in slowing disease progression, their clinical impact remains suboptimal due to poor pharmacokinetic properties and non-curative therapy. Moreover, the development of effective anti-fibrotic agents targeting collagen synthesis is hindered by the absence of robust, cost-effective, high-throughput drug screening platforms. In this study, we established a novel screening system designed to identify small molecules that inhibit the expression of the COL1A2 gene, which encodes type I collagen. Utilizing this system, we screened a library of natural and synthetic compounds developed at Nagasaki University and identified lamellarin D as a potent inhibitor of COL1A2 expression and subsequent type I collagen production. These findings suggest that lamellarin D, through its unique molecular mechanism, may serve as the foundation for the development of a new class of IPF treatments aimed at targeting the underlying fibrotic processes.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202401001"},"PeriodicalIF":3.6,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143062834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and Synthesis of Tetrahydropyrrolo[3,4-c]Pyrazole Sigma-1 Receptor Ligands. 四氢吡咯[3,4-c]吡唑Sigma-1受体配体的设计与合成。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-01-30 DOI: 10.1002/cmdc.202401015
Giuseppe Cosentino, Maria Dichiara, Giuliana Costanzo, Alessandro Coco, Lorella Pasquinucci, Agostino Marrazzo, Antonio Rescifina, Emanuele Amata
{"title":"Design and Synthesis of Tetrahydropyrrolo[3,4-c]Pyrazole Sigma-1 Receptor Ligands.","authors":"Giuseppe Cosentino, Maria Dichiara, Giuliana Costanzo, Alessandro Coco, Lorella Pasquinucci, Agostino Marrazzo, Antonio Rescifina, Emanuele Amata","doi":"10.1002/cmdc.202401015","DOIUrl":"10.1002/cmdc.202401015","url":null,"abstract":"<p><p>This study presents a series of tetrahydropyrrolo[3,4-c]pyrazole-based compounds designed as sigma-1 receptor (S1R) ligands, focusing on optimizing affinity and reducing off-target effects. We synthesized various derivatives from commercially available precursors and, through radioligand binding assays, assessed their binding affinity for S1R and sigma-2 receptor (S2R). Compound 19 (AD417), containing a benzyl group and an amide substituent, demonstrated notable S1R affinity (K<sub>i</sub>=75 nM) with 6-fold selectivity over S2R. Modifications on the pyrrolidine nitrogen were crucial in enhancing receptor interaction, as the protonated nitrogen likely interacts with Glu172 within the S1R binding site. Furthermore, to address hERG potassium ion channel inhibition, a known limitation in S1R drug development, we evaluated compound 19's cardiotoxicity potential. With an experimental hERG IC<sub>50</sub> of 5.8 μM, significantly higher than verapamil's IC<sub>50</sub> of 0.41 μM, and haloperidol's IC<sub>50</sub> of 0.16 μM, compound 19 showed a safer profile, suggesting a reduced risk of cardiotoxicity. These findings underscore the role of nitrogen accessibility, structural flexibility, and functional group modifications in optimizing S1R ligand interactions and provide a promising foundation for developing safer S1R-targeted therapeutics with minimized hERG-related risks.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202401015"},"PeriodicalIF":3.6,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143062831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABT, Elacridar and Bile-Duct Cannulated Rats: Tools to Understand Pharmacokinetics ABT,埃拉西达和胆管插管大鼠:了解药代动力学的工具。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-01-28 DOI: 10.1002/cmdc.202400995
Gilles Ouvry
{"title":"ABT, Elacridar and Bile-Duct Cannulated Rats: Tools to Understand Pharmacokinetics","authors":"Gilles Ouvry","doi":"10.1002/cmdc.202400995","DOIUrl":"10.1002/cmdc.202400995","url":null,"abstract":"<p>Optimizing pharmacokinetics is an integral part of drug design, albeit a lesser understood one from the medicinal chemist's perspective. Over the years, molecular tools and experimental strategies have been developed to better understand the fate of compounds. Among these, the use of aminobenzotriazole (ABT), elacridar and bile-duct cannulated rats have been instrumental in gaining valuable PK insights, with a direct impact on drug design.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":"20 8","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning-Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2a. 机器学习驱动下发现结构相关的天然产物作为心脏钙泵SERCA2a的激活剂。
IF 3.6 4区 医学
ChemMedChem Pub Date : 2025-01-23 DOI: 10.1002/cmdc.202400913
Carlos Cruz-Cortés, Eli Fernández-de Gortari, Rodrigo Aguayo-Ortiz, Jaroslava Šeflová, Adam Ard, Martin Clasby, Justus Anumonwo, L Michel Espinoza-Fonseca
{"title":"Machine Learning-Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2a.","authors":"Carlos Cruz-Cortés, Eli Fernández-de Gortari, Rodrigo Aguayo-Ortiz, Jaroslava Šeflová, Adam Ard, Martin Clasby, Justus Anumonwo, L Michel Espinoza-Fonseca","doi":"10.1002/cmdc.202400913","DOIUrl":"10.1002/cmdc.202400913","url":null,"abstract":"<p><p>A key molecular dysfunction in heart failure is the reduced activity of the cardiac sarcoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA2a) in cardiac muscle cells. Reactivating SERCA2a improves cardiac function in heart failure models, making it a validated target and an attractive therapeutic approach for heart failure therapy. However, finding small-molecule SERCA2a activators is challenging. In this study, we used a machine learning-based virtual screening to identify SERCA2a activators among 57,423 natural products. The machine learning model identified ten structurally related natural products from Zingiber officinale, Aframomum melegueta, Alpinia officinarum, Alpinia oxyphylla, and Capsicum (chili peppers) as SERCA2a activators. Initial ATPase assays showed seven of these activate SERCA at low micromolar concentrations. Notably, two natural products, Yakuchinone A and Alpinoid D displayed robust concentration-dependent responses in primary ATPase activity assays, efficient lipid bilayer binding and permeation in atomistic simulations, and enhanced intracellular Ca<sup>2+</sup> transport in adult mouse cardiac cells. While these natural products exert off-target effects on Ca<sup>2+</sup> signaling, these compounds offer promising avenues for the design and optimization of lead compounds. In conclusion, this study increases the array of calcium pump effectors and provides new scaffolds for the development of novel SERCA2a activators as new therapies for heart failure.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202400913"},"PeriodicalIF":3.6,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143031558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信